ArticleExperimental and therapeutic medicine2023

Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis.

Zheng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.